Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-042479

VP, Chief Accounting Officer gave up 860 shares (to pay taxes)

  • VP, Chief Accounting Officer acquired 2,485 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2023-07-13 Option exercise +552 24,237 D
Peraza Lisa VP, Chief Accounting Officer 2023-07-13 Option exercise +1,933 26,170 D
Peraza Lisa VP, Chief Accounting Officer 2023-07-13 Shares withheld for taxes −860 $1.31 $1,127 25,310 D
Derivatives
Peraza Lisa VP, Chief Accounting Officer 2023-07-13 Option exercise · Restricted Stock Units −552 2,760 D
Peraza Lisa VP, Chief Accounting Officer 2023-07-13 Option exercise · Restricted Stock Units −1,933 9,896 D
Loading xslF345X05/doc4.xml…